SGLT-2 Inhibition Beyond Glycemic Control: Exploring the Neuroprotective Properties of Dapagliflozin in Diabetes-Related Neurodegeneration . CDF [Internet]. 2024 Nov. 20 [cited 2026 Jun. 13];53(03):6207-13. Available from: https://cuestionesdefisioterapia.com/index.php/es/article/view/3770